(Q29616803)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16518375

30 April 2017

main subject

multiple drug resistance

0 references

author name string

Szakács G

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16518375

30 April 2017

Paterson JK

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16518375

30 April 2017

Ludwig JA

3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16518375

30 April 2017

Booth-Genthe C

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16518375

30 April 2017

Gottesman MM

5

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16518375

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16518375

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

March 2006

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16518375

Nature Reviews Drug Discovery

30 April 2017

published in

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16518375

30 April 2017

volume

5

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16518375

30 April 2017

page(s)

219-34

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16518375

30 April 2017

issue

3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16518375

The human ATP-binding cassette (ABC) transporter superfamily

30 April 2017

cites work

1 reference

The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver

1 May 2017

1 reference

Phosphatidylcholine translocase: a physiological role for the mdr2 gene

1 May 2017

1 reference

MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine

1 May 2017

1 reference

A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis

1 May 2017

1 reference

Tissue distribution and induction of human multidrug resistant protein 3

1 May 2017

1 reference

Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum

1 May 2017

1 reference

Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel

1 May 2017

1 reference

MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2',3'-dideoxycytidine and 9'-(2'-phosphonylmethoxyethyl)adenine

1 May 2017

1 reference

Multidrug resistance in cancer: role of ATP-dependent transporters

1 May 2017

1 reference

Calcein assay for multidrug resistance reliably predicts therapy response and survival rate in acute myeloid leukaemia

1 May 2017

1 reference

Tumour stem cells and drug resistance

1 May 2017

1 reference

The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux

1 May 2017

1 reference

Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins

1 May 2017

1 reference

A multidrug resistance transporter from human MCF-7 breast cancer cells

1 May 2017

1 reference

The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype

1 May 2017

1 reference

MRP3, an organic anion transporter able to transport anti-cancer drugs

1 May 2017

1 reference

Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport

1 May 2017

1 reference

Hepatic secretion of conjugated drugs and endogenous substances

1 May 2017

1 reference

Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5

1 May 2017

1 reference

ABC Transporters: From Microorganisms to Man

1 May 2017

1 reference

Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells

21 January 2018

1 reference

RETRACTED: Structure of MsbA from E. coli: a homolog of the multidrug resistance ATP binding cassette (ABC) transporters

21 January 2018

1 reference

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

21 January 2018

1 reference

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

21 January 2018

1 reference

The physiological function of drug-transporting P-glycoproteins

21 January 2018

1 reference

Potential role of drug transporters in the pathogenesis of medically intractable epilepsy

21 January 2018

1 reference

Biochemical, cellular, and pharmacological aspects of the multidrug transporter

21 January 2018

1 reference

Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.

21 January 2018

1 reference

Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein

21 January 2018

1 reference

The reversal of multidrug resistance: an update

21 January 2018

1 reference

MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping

21 January 2018

1 reference

Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain

21 January 2018

1 reference

Structural, mechanistic and clinical aspects of MRP1.

21 January 2018

1 reference

Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells

21 January 2018

1 reference

Mrp2-deficiency in the rat impairs biliary and intestinal excretion and influences metabolism and disposition of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo

21 January 2018

1 reference

Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene

21 January 2018

1 reference

Overexpression of cMOAT (MRP2/ABCC2) is associated with decreased formation of platinum-DNA adducts and decreased G2-arrest in melanoma cells resistant to cisplatin

21 January 2018

1 reference

Analysis of ATP-binding cassette transporter expression in drug-selected cell lines by a microarray dedicated to multidrug resistance.

21 January 2018

1 reference

Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane

21 January 2018

1 reference

The MRP family of drug efflux pumps

21 January 2018

1 reference

A family of drug transporters: the multidrug resistance-associated proteins.

21 January 2018

1 reference

MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs

21 January 2018

1 reference

Transport of bile acids, sulfated steroids, estradiol 17-beta-D-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11)

21 January 2018

1 reference

ABCG2 (BCRP) expression in normal and malignant hematopoietic cells

21 January 2018

1 reference

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.

21 January 2018

1 reference

Resistance to antifolates

21 January 2018

1 reference

Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells.

21 January 2018

1 reference

Tyrosine kinase inhibitor resistance in cancer: role of ABC multidrug transporters

21 January 2018

1 reference

The Role of ABC Transporters in Clinical Practice

21 January 2018

1 reference

Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance.

21 January 2018

1 reference

Strategies for overcoming p-glycoprotein-mediated drug resistance in acute myeloblastic leukaemia

21 January 2018

1 reference

The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis

21 January 2018

1 reference

Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications.

21 January 2018

1 reference

Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group

21 January 2018

1 reference

Breast cancer resistance protein in drug resistance of primitive CD34+38- cells in acute myeloid leukemia

21 January 2018

1 reference

Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study

21 January 2018

1 reference

Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein

21 January 2018

1 reference

Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Gr

21 January 2018

1 reference

Multidrug resistance: can new drugs help chemotherapy score against cancer?

21 January 2018

1 reference

Drug interaction studies between paclitaxel (Taxol) and OC144-093--a new modulator of MDR in cancer chemotherapy

21 January 2018

1 reference

VX-710 (biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein

21 January 2018

1 reference

Development of multidrug-resistance convertors: sense or nonsense?

21 January 2018

1 reference

Considerations in the design and development of transport inhibitors as adjuncts to drug therapy

21 January 2018

1 reference

Blockage of drug resistance in vitro by disulfiram, a drug used to treat alcoholism

21 January 2018

1 reference

Herbal modulation of P-glycoprotein

21 January 2018

1 reference

Inhibitors of multidrug efflux transporters: their membrane and protein interactions

21 January 2018

1 reference

Inhibitors of p-glycoprotein--lead identification and optimisation

21 January 2018

1 reference

Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells.

21 January 2018

1 reference

Inhibition of G-protein-coupled receptor function by disruption of transmembrane domain interactions.

21 January 2018

1 reference

Blockade of G protein-coupled receptors and the dopamine transporter by a transmembrane domain peptide: novel strategy for functional inhibition of membrane proteins in vivo

21 January 2018

1 reference

Transmembrane inhibitors of P-glycoprotein, an ABC transporter

21 January 2018

1 reference

Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody

21 January 2018

1 reference

Inhibition of multidrug resistance by immunisation with synthetic P-glycoprotein-derived peptides.

21 January 2018

1 reference

Transcriptional regulation of ABC drug transporters

21 January 2018

1 reference

Inhibition of MDR1 gene expression by chimeric HNA antisense oligonucleotides

21 January 2018

1 reference

Selective inhibition of P-glycoprotein expression in multidrug-resistant tumor cells by a designed transcriptional regulator.

21 January 2018

1 reference

Strategies for inhibition of MDR1 gene expression.

21 January 2018

1 reference

In vivo RNA interference-mediated ablation of MDR1 P-glycoprotein

21 January 2018

1 reference

Circumvention of P-GP MDR as a function of anthracycline lipophilicity and charge

21 January 2018

1 reference

Pegylated liposomal doxorubicin: proof of principle using preclinical animal models and pharmacokinetic studies

21 January 2018

1 reference

Increased intracellular drug accumulation and complete chemosensitization achieved in multidrug-resistant solid tumors by co-administering valspodar (PSC 833) with sterically stabilized liposomal doxorubicin.

21 January 2018

1 reference

Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar.

21 January 2018

1 reference

Ultrasound-enhanced tumor targeting of polymeric micellar drug carriers

21 January 2018

1 reference

Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies

21 January 2018

1 reference

Drug selection of MDR1-transduced hematopoietic cells ex vivo increases transgene expression and chemoresistance in reconstituted bone marrow in mice

21 January 2018

1 reference

Treatment with inhibitors of caspases, that are substrates of drug transporters, selectively permits chemotherapy-induced apoptosis in multidrug-resistant cells but protects normal cells

21 January 2018

1 reference

A monoclonal antibody-Pseudomonas toxin conjugate that specifically kills multidrug-resistant cells

21 January 2018

1 reference

Monoclonal anti-P-glycoprotein antibody-dependent killing of multidrug-resistant tumor cells by human mononuclear cells.

21 January 2018

1 reference

Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection

21 January 2018

1 reference

The cyclosporin PSC 833 increases survival and delays engraftment of human multidrug-resistant leukemia cells in xenotransplanted NOD-SCID mice

21 January 2018

1 reference

2-Deoxy-D-glucose preferentially kills multidrug-resistant human KB carcinoma cell lines by apoptosis

21 January 2018

1 reference

The human KB multidrug-resistant cell line KB-C1 is hypersensitive to inhibitors of glycosylation

21 January 2018

1 reference

The preferential induction of apoptosis in multidrug-resistant KB cells by 5-fluorouracil

21 January 2018

1 reference

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines

21 January 2018

1 reference

Multiple physiological functions for multidrug transporter P-glycoprotein?

21 January 2018

1 reference

P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway

21 January 2018

1 reference

Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells

21 January 2018

1 reference

Verapamil and its derivative trigger apoptosis through glutathione extrusion by multidrug resistance protein MRP1.

21 January 2018

1 reference

Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.

21 January 2018

1 reference

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

21 January 2018

1 reference

Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells.

21 January 2018

1 reference

Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine

21 January 2018

1 reference

Patterns of cross-resistance in a multidrug-resistant small-cell lung carcinoma cell line

21 January 2018

1 reference

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

21 January 2018

1 reference

A high-throughput screening microplate test for the interaction of drugs with P-glycoprotein

21 January 2018

1 reference

Multidrug resistance reversal agents

21 January 2018

1 reference

Clinical relevance of P-glycoprotein in drug therapy

21 January 2018

1 reference

Unmasking the dynamic interplay between efflux transporters and metabolic enzymes.

21 January 2018

1 reference

Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense

21 January 2018

1 reference

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

21 January 2018

1 reference

Multidrug resistance related molecules in human and murine lung

21 January 2018

1 reference

Tissue and cell distribution of the multidrug resistance-associated protein (MRP) in mouse intestine and kidney

21 January 2018

1 reference

The complexities of hepatic drug transport: current knowledge and emerging concepts.

21 January 2018

1 reference

High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease.

21 January 2018

1 reference

ATP binding cassette transporter gene expression in rat liver progenitor cells

21 January 2018

1 reference

Role of MDR1 and MRP1 in trophoblast cells, elucidated using retroviral gene transfer

21 January 2018

1 reference

Cellular localization and functional expression of P-glycoprotein in rat astrocyte cultures.

21 January 2018

1 reference

Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier

21 January 2018

1 reference

Involvement of multidrug resistance associated protein 1 (Mrp1) in the efflux transport of 17beta estradiol-D-17beta-glucuronide (E217betaG) across the blood-brain barrier

21 January 2018

1 reference

Plasma membrane localization of multidrug resistance-associated protein homologs in brain capillary endothelial cells

21 January 2018

1 reference

Mrp4 confers resistance to topotecan and protects the brain from chemotherapy

21 January 2018

1 reference

Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy.

21 January 2018

1 reference

Brain access and anticonvulsant efficacy of carbamazepine, lamotrigine, and felbamate in ABCC2/MRP2-deficient TR- rats

21 January 2018

1 reference

Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity

21 January 2018

1 reference

Expression of members of the multidrug resistance protein family in human term placenta

21 January 2018

1 reference

The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk.

21 January 2018

1 reference

21 January 2018

1 reference

The multidrug resistance-associated protein 1 transports methoxychlor and protects the seminiferous epithelium from injury

21 January 2018

1 reference

Multidrug resistance genes and p-glycoprotein in the testis of the rat, mouse, Guinea pig, and human

21 January 2018

1 reference

Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites.

21 January 2018

1 reference

Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane

21 January 2018

1 reference

Mitoxantrone resistance in a small cell lung cancer cell line is associated with ABCA2 upregulation.

21 January 2018

1 reference

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors

21 January 2018

1 reference

HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.

21 January 2018

1 reference

Interaction of tyrosine kinase inhibitors with the human multidrug transporter proteins, MDR1 and MRP1.

21 January 2018

1 reference

ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1.

21 January 2018

1 reference

MRP1 and glucosylceramide are coordinately over expressed and enriched in rafts during multidrug resistance acquisition in colon cancer cells

21 January 2018

1 reference

Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein

21 January 2018

1 reference

Intestinal transport of irinotecan in Caco-2 cells and MDCK II cells overexpressing efflux transporters Pgp, cMOAT, and MRP1.

21 January 2018

1 reference

Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro.

21 January 2018

1 reference

Human multidrug resistance associated protein 4 confers resistance to camptothecins.

21 January 2018

1 reference

BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells.

21 January 2018

1 reference

Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine

21 January 2018

1 reference

MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecid

21 January 2018

1 reference

Role of MRP2 and GSH in intrahepatic cycling of toxins

21 January 2018

1 reference

Breast cancer resistance protein (BCRP/ABCG2).

21 January 2018

1 reference

Multidrug resistance in cancer chemotherapy and xenobiotic protection mediated by the half ATP-binding cassette transporter ABCG2.

21 January 2018

1 reference

Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3).

21 January 2018

1 reference

The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolates.

21 January 2018

1 reference

The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites

21 January 2018

1 reference

Breast cancer resistance protein (BCRP/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors

21 January 2018

1 reference

Mutations of charged amino acids in or near the transmembrane helices of the second membrane spanning domain differentially affect the substrate specificity and transport activity of the multidrug resistance protein MRP1 (ABCC1).

21 January 2018

1 reference

Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance.

21 January 2018

1 reference

Almost serendipity: alcoholism drug reverses drug resistance in vitro.

21 January 2018

1 reference

Pheophorbide a is a specific probe for ABCG2 function and inhibition.

21 January 2018

1 reference

Evaluation of the binding of the tricyclic isoxazole photoaffinity label LY475776 to multidrug resistance associated protein 1 (MRP1) orthologs and several ATP- binding cassette (ABC) drug transporters

21 January 2018

1 reference

Modulation of P-glycoprotein but not MRP1- or BCRP-mediated drug resistance by LY335979.

21 January 2018

1 reference

The molecular interaction of the high affinity reversal agent XR9576 with P-glycoprotein

21 January 2018

1 reference

Cyclohexyl-linked tricyclic isoxazoles are potent and selective modulators of the multidrug resistance protein (MRP1).

21 January 2018

1 reference

Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study

21 January 2018

1 reference

A randomised clinical study of verapamil in addition to combination chemotherapy in small cell lung cancer. West of Scotland Lung Cancer Research Group, and the Aberdeen Oncology Group

21 January 2018

1 reference

A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study

21 January 2018

1 reference

Results of a phase III, double-blind, placebo-controlled trial of megestrol acetate modulation of P-glycoprotein-mediated drug resistance in the first-line management of small-cell lung carcinoma

21 January 2018

1 reference

Comparison of 'sequential' versus 'standard' chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML-R trial

21 January 2018

1 reference

Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study.

21 January 2018

1 reference

Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914).

21 January 2018

1 reference

Quinine as a multidrug resistance inhibitor: a phase 3 multicentric randomized study in adult de novo acute myelogenous leukemia

21 January 2018

1 reference

Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995)

21 January 2018

1 reference

Localisation of breast cancer resistance protein in microvessel endothelium of human brain

21 January 2018

1 reference

Cellular pharmacology of mitoxantrone in p-glycoprotein-positive and -negative human myeloid leukemic cell lines.

21 January 2018

1 reference

Multidrug resistance protein 1 (MRP1, ABCC1) mediates resistance to mitoxantrone via glutathione-dependent drug efflux

21 January 2018

1 reference

Direct evidence that saquinavir is transported by multidrug resistance-associated protein (MRP1) and canalicular multispecific organic anion transporter (MRP2).

21 January 2018

1 reference

Cyclosporins as drug resistance modifiers

21 January 2018

1 reference

The molecular basis of the action of disulfiram as a modulator of the multidrug resistance-linked ATP binding cassette transporters MDR1 (ABCB1) and MRP1 (ABCC1).

21 January 2018

1 reference

Cyclosporin A is a broad-spectrum multidrug resistance modulator

21 January 2018

1 reference

Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR.

21 January 2018

1 reference

Reversal of multidrug resistance by B859-35, a metabolite of B859-35, niguldipine, verapamil and nitrendipine

21 January 2018

1 reference

Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance

21 January 2018

1 reference

Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells

21 January 2018

1 reference

Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic.

31 March 2020

1 reference

Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides.

31 March 2020

1 reference

Diagnostics of multidrug resistance in cancer

31 March 2020

1 reference

P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia

31 March 2020

1 reference

Quinine improves results of intensive chemotherapy (IC) in myelodysplastic syndromes (MDS) expressing P-glycoprotein (PGP). Updated results of a randomized study. Groupe Français des Myélodysplasies (GFM) and Groupe GOELAMS

31 March 2020

1 reference

Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working

31 March 2020

1 reference

Gain and loss of hypersensitivity to resistance modifiers in multidrug resistant Chinese hamster ovary cells

31 March 2020

1 reference

Are the major effects of P-glycoprotein modulators due to altered pharmacokinetics of anticancer drugs?

31 March 2020

1 reference

Differential inhibition by cyclosporins of primary-active ATP-dependent transporters in the hepatocyte canalicular membrane

31 March 2020

1 reference

Methods to detect P-glycoprotein and implications for other drug resistance-associated proteins

31 March 2020

1 reference

Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan

31 March 2020

1 reference

Transport function and hepatocellular localization of mrp6 in rat liver

31 March 2020

1 reference

Involvement ofMDR1 P-glycoprotein in multifactorial resistance to methotrexate

31 March 2020

1 reference

Quinidine as a resistance modulator of epirubicin in advanced breast cancer: mature results of a placebo-controlled randomized trial

31 March 2020

1 reference

Verapamil increases the survival of patients with anthracycline-resistant metastatic breast carcinoma

31 March 2020

1 reference

Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP

31 March 2020

1 reference

Analysis of the in vivo functions of Mrp3.

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Regulation of the MDR1 gene by transcriptional repressors selected using peptide combinatorial libraries

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16518375

30 April 2017

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

400221

1042314065

0 references

400221

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16518375

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017